Medical Stop Loss
We offer flexible specific and aggregate coverage, insurance, reinsurance, risk share, and underwriting-only stop loss solutions
Complete array of coverage options for both large and small self-funded groups
Specific
Coverage per individual participant limits high-cost claimant exposure
Available medical-only, or medical with Rx
Aggregate
Coverage for entire group limits overall claims costs
Can include medical-only or a combination of medical with Rx, dental, and vision
Reinsurance
We offer multiple stop loss reinsurance arrangements to help you manage – and mitigate – risk
Gene Therapy
Solutions to manage the high costs of gene therapies
Cost Containment Solutions
Access to a variety of partnerships with specialty vendors and service providers that support clinical intervention and cost-saving initiatives to manage exposure to high-cost claims
BCS Stop Loss customers have access to BCS RiskNavigator and cost containment solutions.
-
Now Quoting Gene Therapy Stop Loss for 2026
Understanding Gene Therapy Stop Loss Gene therapies offer the promise of potential cures for disease and genetic disorders, yet come at unprecedented costs ($2M to $4M per treatment). Self-funded employers are exposed to both frequency and severity of these catastrophic $2-4M claims. That’s why BCS has developed gene therapy stop loss products, known as Stop